Electric Vehicle Charging Infrastructure Market
Description
Electric Vehicle Charging Infrastructure Market Summary
The global electric vehicle charging infrastructure market size was estimated at USD 40.22 billion in 2025, and is projected to reach USD 238.82 billion by 2033, growing at a CAGR of 25.0% from 2026 to 2033. Growing concerns over carbon emissions and growing adoption of electric vehicles (EVs) across the globe are major factors behind the growth of the electric vehicle charging infrastructure market.
Government regulations and tax exemptions further promote the adoption of EVs, thus driving the demand for EV charging infrastructure solutions. In addition, factors such as rapid technological advancements in battery technology and decreasing cost of lithium-ion battery are expected to contribute to the growth of the market during the forecast period. In recent years, EVs have gained significant popularity, notably driven by increasing environmental awareness and a focus on sustainability.
As the adoption of EVs continues to expand, governments globally are implementing regulations aimed at supporting industry growth, thereby contributing to the EV charging infrastructure market. For instance, the US Federal Government provides a tax credit of up to USD 7,500 for qualifying EVs. In addition, in Canada, the government aims to achieve a target where all light-duty vehicles sold are zer electric vehicleso-emission by 2040. Such government initiatives to promote EV adoption are expected to boost market growth.
Developments in battery and charging technology are poised to transform the global automotive sector. Enhanced battery technology has extended the travel range of electric vehicles per charge, while new chargers can now recharge batteries at faster rates, attracting greater consumer interest in electric vehicles. This surge in demand is fueling the need for electric vehicle charging stations. Additionally, the increasing focus on autonomous and shared mobility is expected to drive further adoption of electric vehicles, positively impacting the market for electric vehicle charging infrastructure.
Despite the rising popularity of electric vehicles and EV charging infrastructure, there are some challenges that could hamper market growth. High initial cost of installing EV charging infrastructure, lack of dedicated charging space, and fluctuating power tariffs are major challenges in the EV charging infrastructure market. There are several costs associated with charging infrastructure, including installation costs, operational costs, and maintenance costs. Furthermore, other tasks, such as project management, feasibility analysis, and consultancy, incur additional costs. Thus, high costs involved in rolling out the infrastructure can potentially hinder market growth.
Electric Vehicle Charging Infrastructure Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global electric vehicle charging infrastructure market report based on charger type, charging type, connector type, level of charging, connectivity, operation, application, and region.
The global electric vehicle charging infrastructure market size was estimated at USD 40.22 billion in 2025, and is projected to reach USD 238.82 billion by 2033, growing at a CAGR of 25.0% from 2026 to 2033. Growing concerns over carbon emissions and growing adoption of electric vehicles (EVs) across the globe are major factors behind the growth of the electric vehicle charging infrastructure market.
Government regulations and tax exemptions further promote the adoption of EVs, thus driving the demand for EV charging infrastructure solutions. In addition, factors such as rapid technological advancements in battery technology and decreasing cost of lithium-ion battery are expected to contribute to the growth of the market during the forecast period. In recent years, EVs have gained significant popularity, notably driven by increasing environmental awareness and a focus on sustainability.
As the adoption of EVs continues to expand, governments globally are implementing regulations aimed at supporting industry growth, thereby contributing to the EV charging infrastructure market. For instance, the US Federal Government provides a tax credit of up to USD 7,500 for qualifying EVs. In addition, in Canada, the government aims to achieve a target where all light-duty vehicles sold are zer electric vehicleso-emission by 2040. Such government initiatives to promote EV adoption are expected to boost market growth.
Developments in battery and charging technology are poised to transform the global automotive sector. Enhanced battery technology has extended the travel range of electric vehicles per charge, while new chargers can now recharge batteries at faster rates, attracting greater consumer interest in electric vehicles. This surge in demand is fueling the need for electric vehicle charging stations. Additionally, the increasing focus on autonomous and shared mobility is expected to drive further adoption of electric vehicles, positively impacting the market for electric vehicle charging infrastructure.
Despite the rising popularity of electric vehicles and EV charging infrastructure, there are some challenges that could hamper market growth. High initial cost of installing EV charging infrastructure, lack of dedicated charging space, and fluctuating power tariffs are major challenges in the EV charging infrastructure market. There are several costs associated with charging infrastructure, including installation costs, operational costs, and maintenance costs. Furthermore, other tasks, such as project management, feasibility analysis, and consultancy, incur additional costs. Thus, high costs involved in rolling out the infrastructure can potentially hinder market growth.
Electric Vehicle Charging Infrastructure Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global electric vehicle charging infrastructure market report based on charger type, charging type, connector type, level of charging, connectivity, operation, application, and region.
- Charger Type Outlook (Revenue, USD Billion, 2021 - 2033)
- Slow Charger
- Fast Charger
- Charging Type Outlook (Revenue, USD Billion, 2021 - 2033)
- AC
- DC
- Connector Type Outlook (Revenue, USD Billion, 2021 - 2033)
- CHAdeMO
- CCS
- Others
- Level of Charging Outlook (Revenue, USD Billion, 2021 - 2033)
- Level 1
- Level 2
- Level 3
- Connectivity Outlook (Revenue, USD Billion, 2021 - 2033)
- Non-connected Charging Stations
- Connected Charging Stations
- Operation Outlook (Revenue, USD Billion, 2021 - 2033)
- Mode 1
- Mode 2
- Mode 3
- Mode 4
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Commercial
- Destination Charging Stations
- Highway Charging Stations
- Bus Charging Stations
- Fleet Charging Stations
- Other Charging Stations
- Residential
- Private Houses
- Apartments/Societies
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Norway
- Netherlands
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Middle East and Africa (MEA)
- KSA
- UAE
- South Africa
Table of Contents
160 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Vector Type
- 1.2.2. Application
- 1.2.3. End use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.4.1. Increasing demand for gene therapies
- 3.4.2. Rising investments in research and development with immense funding support
- 3.5. Market Restraint Analysis
- 3.5.1. Complex manufacturing process.
- 3.5.2. Regulatory challenges and intellectual property issues.
- 3.6. Business Environment Analysis
- 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.6.2. Porter’s Five Forces Analysis
- Chapter 4. Viral Vector Market: Vector Type Size Estimated & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Viral vector market: Vector Type Movement Analysis
- 4.3. Adeno-associated virus (AAV)
- 4.3.1. Adeno-associated virus (AAV) Market, 2021 - 2033 (USD Million)
- 4.4. Adenovirus
- 4.4.1. Adenovirus Market, 2021 - 2033 (USD Million)
- 4.5. Lentivirus
- 4.5.1. Lentivirus Market, 2021 - 2033 (USD Million)
- 4.6. Retrovirus
- 4.6.1. Retrovirus Market, 2021 - 2033 (USD Million)
- 4.7. Others
- 4.7.1. Others Market, 2021 - 2033 (USD Million)
- Chapter 5. Viral Vector Market: Application Size Estimated & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Viral vector market: Application Movement Analysis
- 5.3. Cell and Gene Therapy
- 5.3.1. Cell and Gene Therapy Market, 2021 - 2033 (USD Million)
- 5.4. Vaccine
- 5.4.1. Vaccine Market, 2021 - 2033 (USD Million)
- 5.5. Biopharmaceutical & Pharmaceuticals Discovery
- 5.5.1. Biopharmaceutical & Pharmaceuticals Discovery Market, 2021 - 2033 (USD Million)
- Chapter 6. Viral Vector Market: End Use Size Estimated & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Viral vector market: End Use Movement Analysis
- 6.3. Pharmaceutical and Biotechnology Companies
- 6.3.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
- 6.4. Academic and Research Institutes
- 6.4.1. Academic and Research Institutes Market, 2021 - 2033 (USD Million)
- 6.5. CROs & CMOs
- 6.5.1. CROs and CMOs Market, 2021 - 2033 (USD Million)
- Chapter 7. Viral Vector Market: Regional Size Estimated & Trend Analysis
- 7.1. Viral Vector Market Share by Region, 2025 & 2033
- 7.2. North America
- 7.2.1. North America Viral vector market, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. U.S. viral vector market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Canada Viral vector market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Mexico Viral vector market, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Viral vector market, 2021 - 2033 (USD Million)
- 7.3.2. Germany
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. Germany Viral vector market, 2021 - 2033 (USD Million)
- 7.3.3. UK
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. UK Viral vector market, 2021 - 2033 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. France Viral vector market, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Italy Viral vector market, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Spain Viral vector market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Denmark Viral vector market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Sweden Viral vector market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Norway Viral vector market, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Viral vector market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Japan Viral vector market, 2021 - 2033 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. China Viral vector market, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. India Viral vector market, 2021 - 2033 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. South Korea Viral vector market, 2021 - 2033 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Australia Viral vector market, 2021 - 2033 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Thailand Viral vector market, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Viral vector market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Brazil Viral vector market, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Argentina Viral vector market, 2021 - 2033 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Viral vector market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. South Africa Viral vector market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Saudi Arabia Viral vector market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. UAE Viral vector market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Kuwait Viral vector market, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Profiles/Listing
- 8.3.1. Oxford Biomedica
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Thermo Fisher Scientific, Inc.
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Lonza.
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Batavia Biosciences B.V.
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Biogen
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Asklepios BioPharmaceutical, Inc. (AskBio)
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Sanofi
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Spark Therapeutics, Inc.
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Regenxbio Inc.
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. uniQURE N.V.
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
